Wells Fargo & Company Trims Aflac (NYSE:AFL) Target Price to $81.00

Aflac (NYSE:AFL) had its price target dropped by investment analysts at Wells Fargo & Company from $83.00 to $81.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 0.90% from the stock’s current price.

A number of other research analysts have also recently commented on AFL. Raymond James increased their target price on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. UBS Group increased their target price on Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a research note on Wednesday, January 10th. StockNews.com cut Aflac from a “hold” rating to a “sell” rating in a research note on Wednesday. Piper Sandler increased their target price on Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Finally, Keefe, Bruyette & Woods increased their target price on Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a research note on Wednesday. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $81.85.

Aflac Trading Up 0.8 %

Shares of AFL stock opened at $80.28 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. Aflac has a 52-week low of $64.10 and a 52-week high of $86.26. The company has a market capitalization of $46.19 billion, a PE ratio of 10.36, a price-to-earnings-growth ratio of 2.27 and a beta of 0.91. The business’s fifty day moving average is $81.88 and its 200 day moving average is $81.36.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The business had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $4.44 billion. During the same quarter last year, the business posted $1.29 EPS. On average, equities research analysts anticipate that Aflac will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total transaction of $239,190.00. Following the completion of the sale, the director now owns 5,592 shares of the company’s stock, valued at $445,850.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Thomas J. Kenny sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the sale, the director now owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total transaction of $239,190.00. Following the sale, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The disclosure for this sale can be found here. Over the last three months, insiders have sold 46,493 shares of company stock valued at $3,765,706. 0.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Aflac

Several institutional investors and hedge funds have recently made changes to their positions in AFL. Flputnam Investment Management Co. grew its position in Aflac by 0.5% in the 4th quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock worth $2,065,000 after purchasing an additional 122 shares during the period. ICA Group Wealth Management LLC grew its position in Aflac by 4.3% in the 4th quarter. ICA Group Wealth Management LLC now owns 2,974 shares of the financial services provider’s stock worth $245,000 after purchasing an additional 122 shares during the period. Baystate Wealth Management LLC grew its position in Aflac by 24.1% in the 3rd quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock worth $52,000 after purchasing an additional 131 shares during the period. Dominguez Wealth Management Solutions Inc. grew its position in Aflac by 0.5% in the 3rd quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock worth $1,916,000 after purchasing an additional 132 shares during the period. Finally, Brighton Jones LLC grew its position in Aflac by 2.3% in the 3rd quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock worth $472,000 after purchasing an additional 136 shares during the period. Institutional investors own 67.44% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.